Lonza Group AG Lonza Group AG

Lonza Group AG

LONN

Pozycja w akcjach #444
Lonza Group AG, together with its subsidiaries, operates as a contract... Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Integrated Biologics; Advanced Synthesis; and Specialized Modalities segments. The Integrated Biologics segment offers CDMO biologics services from clinical development, drug substance, and drug product manufacturing; and operates mammalian and drug product platforms. Its Advanced Synthesis segment manufactures antibody-drug conjugates (ADCs) and other bioconjugates, small molecules, and highly potent active pharmaceutical ingredients; and operates small molecules and bioconjugates platforms. The Specialized Modalities segment operates various technologies, such as spanning cell & gene, microbial, bioscience, and mRNA. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
Cena akcji
$764.28
Kapitalizacja rynkowa
$53.38B
Zmiana (1 dzień)
0.99%
Zmiana (1 rok)
8.63%
Kraj
CH
Handel Lonza Group AG (LONN)

Kategoria

Healthcare
Historia ceny akcji dla Lonza Group AG (LONN)
Najwyższa cena zamknięcia: $758.47 dnia 2026-10-01

Najniższa cena zamknięcia: $55.45 dnia 1999-11-01
Historia cen akcji firmy Lonza Group AG od 1999 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 2.71%
2025 12.69%
2024 52.26%
2023 -21.39%
2022 -38.27%
2021 29.85%
2020 78.48%
2019 17.36%
2018 12.75%
2017 66.47%
2016 7.54%
2015 39.65%
2014 24.10%
2013 74.91%
2012 -11.33%
2011 -26.82%
2010 12.01%
2009 -13.00%
2008 -29.50%
2007 34.20%
2006 46.37%
2005 8.46%
2004 5.02%
2003 -11.00%
2002 -13.66%
2001 22.46%
2000 -6.51%
1999 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$536.91 25.90%
US
$230.20 757.36%
US
$137.83 -3.78%
AU
$892.44 9.61%
NL
$291.76 2.51%
BE